Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Internal Medicine
  •  Nutrition and Food Science
  •  Microbiology
  •  Emergency Medicine and Critical Care
  •  Renal Disease
  •  Gastroenterology
  •  Vascular Medicine
  •  Orthopedic Sugery

Abstract

Citation: Ann Clin Case Rep. 2023;8(1):2454.DOI: 10.25107/2474-1655.2454

Efficacy of Co-Adjuvant Melatonin and Resveratrol Chronotherapy for Pregnancy Achievement in Premature Ovarian Failure (POF)

Pagano ES1,2,3*, Peña J4 and Spinedi E5

1Department of Child Health, School of Medicine, University of Missouri, USA
2Institute for Biomedical Research (BIOMED), National Research Council of Argentina (CONICET),
3Pontifical Catholic University of Argentina (UCA), Argentina 4Centro Médico Billinghurst, Argentina
5Centre of Experimental and Applied Endocrinology (CENEXA; UNLP-CONICET), La Plata Medical School UNLP, Argentina

*Correspondance to: Eleonora S Pagano 

 PDF  Full Text Case Report | Open Access

Abstract:

Premature Ovarian Failure/Insufficiency (POF/POI) is a severe chronic female condition characterized by low peripheral E2 and FSH levels before 40 years age. Available therapy did not demonstrate any significant improvement in fertility rate, delaying menopausal symptomatology, and long-term E2 deprivation effects. To restore normal reproductive function, general health and well-being, we proposed to treat POF women with physiological Hormone Replacement Therapy (pHRT), plus Melatonin (MEL) and Resveratrol (RESV). A 39-year-old POF woman, diagnosed after meeting hormonal criteria, emotional distress, miscarriages, and history of familial early menopause and autoimmune disease, poorly tolerated oral contraceptive HRT. Later on, started on natural E2 and micronized Progesterone (P4) treatment; however, no amelioration was achieved. We then started with a "physiological-like¨ schedule, consisting in mimicking a normal female cycle; i.e., hormone doses and timing profile similar to the natural cycle. Because patient was thin, the lowest E2 dose to obtain physiological E2 levels was chosen. After a 3 month-pHRT combined with MEL (50 mg/night) and RESV (100 mg/day) administration, peripheral hormone levels reached not only physiological values but also comparable to those seen on fertile stage, as well as a corresponding cervical mucus pattern and reported sense of “well-being". Five months later, peripheral hCG and abdominal ultrasound confirmed spontaneous pregnancy, on time a healthy baby was born at term by natural delivery. Thus, pHRT and adjusted endogenous rhythm, due to MEL+RESV, could result in novel and multiple health women’s benefits. Therefore pHRT+MEL+RESV therapy should be strongly considered for treating POF/POI and perimenopausal women.

Keywords:

Premature Ovarian Failure (POF); Physiological Hormone Replacement Therapy (PHRT); Melatonin; Resveratrol; Chronotherapy; Menopause; Antioxidants

Cite the Article:

Pagano ES, Peña J, Spinedi E. Efficacy of Co-Adjuvant Melatonin and Resveratrol Chronotherapy for Pregnancy Achievement in Premature Ovarian Failure (POF). Ann Clin Case Rep. 2023; 8: 2454..

Search Our Journal

Journal Indexed In

Articles in PubMed

A New Minimally Invasive Procedure for Muscle, Back, Neck Pain and Radiculopathy - The Myofascial Nerve Block
 PubMed  PMC  PDF  Full Text
Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Using Low-Temperature Plasma Radiofrequency Ablation in the Treatment of an Intractable Hiccup: A Case Report
 Abstract  PDF  Full Text
Combined Variations of Right Hepatic Artery and Vein in a Patient with Liver Cancer Undergoing Hepatectomy: A Case Report and Literature Review
 Abstract  PDF  Full Text
View More...